Mathew Saffarian, DO
Physical Medicine & Rehabilitation · East Lansing, MINPI 1356662332
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $21,000 of the $23,514 with a category attached, or 89.3%. Trice Medical, Inc. accounts for 89.5% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $8,794, more than ten times the $614 reported in 2019. Among physical medicine & rehabilitation clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 100 payments — averaging $235.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Trice Medical, Inc.$21K
- AbbVie$930
- Boston Scientific$828
- Abbott$115
- Medtronic$88
- Fujifilm Sonosite, Inc.$85
- plus $429 from 13 others
What the payments were for
- Consulting fees$21,00089%
- Food & beverage$2,51411%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Trice Medical, Inc. | 11 | $21,040 |
| AbbVie(2 entities) | 50 | $930 |
| Boston Scientific | 13 | $828 |
| Abbott | 4 | $115 |
| Medtronic(2 entities) | 4 | $88 |
| Fujifilm Sonosite, Inc. | 1 | $85 |
| Vertos Medical, Inc. | 1 | $71 |
| Pacira Pharmaceuticals Incorporated | 2 | $54 |
| Amgen(2 entities) | 3 | $51 |
| Globus Medical | 1 | $39 |
| Averitas Pharma Inc. | 2 | $37 |
| Si-bone, Inc. | 1 | $28 |
| Tenex Health Inc. | 1 | $26 |
| Bioventus LLC | 1 | $26 |
| Stratus Medical, LLC | 1 | $24 |
| Stimwave Technologies Incorporated | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Siemens Medical Solutions USA, Inc. | 1 | $16 |
| Avanos Medical | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$23,514 in reported general payments places this provider in the 95th percentile of 469 physical medicine & rehabilitation providers in Michigan.
See all physical medicine & rehabilitation providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 83 | $899 |
| Tizanidine Hcl | 93 | $721 |
| Meloxicam | 154 | $645 |
| Celecoxib | 25 | $583 |
| Baclofen | 19 | $495 |
| Pregabalin | 20 | $220 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 33 | $189 |
| Diclofenac Sodium | 16 | $162 |
| Cephalexin | 12 | $64 |
| Tramadol Hcl | 24 | $56 |
| Diazepam | 18 | $8 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in East Lansing
- Ryan OconnorEast Lansing$4K
- Edward DabrowskiRoseville$167K
- Erika ErlandsonAnn Arbor$54K
- Gianna Maria RodriguezAnn Arbor$41K
- Jason PeterTroy$20K
- David WiersemaSaginaw$17K
- Satyum ParikhWarren$11K
- Reginald KapteynMuskegon$11K
- Emily GladstoneGrand Rapids$10K
- In YoonDearborn$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.